Health Products

IRISPEC CA/CB/CC (2016-04-11)

· Published by Health Canada · Official notice

Details

Alert type: Medical Device Recall
Category: Medical Device
Issue: Medical Devices
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type III
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberCompaniesBrand nameModel or catalog number
004-16
Manufacturer
Iris Diagnostics, a Division of Iris International Inc.
9172 Eton Avenue
Chatsworth
UNITED STATES
A. IRISPEC CA/CB/CC475-1227

Introduction

Affected products 

A. IRISPEC CA/CB/CC

Reason

Iris International has become aware of an issue in which premature degradation of bilirubin for specific lots may lead to bilirubin control failures for the IRIspec CA bilirubin control material. The IRIspec CA control may fail for the bilirubin analyte. The laboratory will be unable to process patient samples until QC passes. Not all bottles within a specific lot may be affected.
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime